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Studies using embryos of the zebraﬁsh Danio rerio (DarT) instead of adult ﬁsh for characterising the (eco-) toxic potential of
chemicals have been proposed as animal replacing methods. Eﬀect analysis at the molecular level might enhance sensitivity,
speciﬁcity, and predictive value of the embryonal studies. The present paper aimed to test the potential of toxicoproteomics
with zebraﬁsh eleutheroembryos for sensitive and speciﬁc toxicity assessment. 2-DE-based toxicoproteomics was performed
applying low-dose (EC10) exposure for 48h with three-model substances Rotenone, 4,6-dinitro-o-cresol (DNOC) and Diclofenac.
By multivariate “pattern-only” PCA and univariate statistical analyses, alterations in the embryonal proteome were detectable
in nonetheless visibly intact organisms and treatment with the three substances was distinguishable at the molecular level.
Toxicoproteomics enabled the enhancement of sensitivity and speciﬁcity of the embryonal toxicity assay and bear the potency
to identify protein markers serving as general stress markers and early diagnosis of toxic stress.
1.Introduction
As ﬁsh are highly developed vertebrates in the aquatic
ecosystems, they are of major relevance in ecotoxicology
mainlyasimportantmodelorganismsfortoxicityassessment
of water pollution. The acute ﬁsh test, for example, [1]
is among the base test set necessary for regulatory risk
assessment of chemicals. Among ﬁsh, the zebraﬁsh (Danio
rerio), a small tropical ﬁsh native to rivers of India and
South Asia [2], has emerged as a popular vertebrate model
in (eco-) toxicology [3–5] because it is unique with respect
to the level of available knowledge and technology and has
many beneﬁts like its rapid development, easy maintenance
in the laboratory, large number of oﬀspring, and access to
experimental manipulation [6]. As the use of ﬁsh embryos
is considered a reﬁnement, if not replacement of animal
experiments [7, 3R principle] and due to the available
knowledge of developmental processes of zebraﬁsh, Nagel
[5] has introduced the embryo test with the zebraﬁsh
Danio rerio test on teratogenicity (DarT) as an alternative
to the acute ﬁsh toxicity test. The DarTa n a l y s e sa c u t e
toxicityinembryosbyscreeninglethaleﬀects,developmental
disorders, and other morphological, sublethal endpoints.
Next to animal replacement, studies on embryonal stages
oﬀer some advantages compared to adults. Test organisms
can be obtained in high numbers and at short breeding time,
cultivation is less cost and time consuming, organisms are of
small size and require no feeding. In Germany, the DarTh a s
already replaced the acute ﬁsh tests for toxicity assessment
of waste water eﬄuents [8] but is not yet extended for use
in chemical risk assessment [9]. Improvement of knowledge
about toxic responses regarding sensitivity, speciﬁcity, and
novel biomarkers increasing the predictive value for possible
long-term eﬀects in the embryonic model system [10]w o u l d
help to advance DarT also for chemical testing.
One possibility to address these challenges might
be the analysis of eﬀects at the molecular level [11].
Genomic studies on early life stages of the zebraﬁsh and
the highly advanced sequencing of the zebraﬁsh genome
(http://www.sanger.ac.uk/Projects/D rerio/) has lead to the
proposalextendingtheDarTassaytotheMolDarTor“Gene-
DarT” (gene expression Danio rerio embryo test) [12–15].2 International Journal of Proteomics
This approach is based on studying gene expression proﬁles
as additional toxicological endpoints and combines both
early eﬀect diagnosis and mode of action analysis [16].
The present paper aims to extend the DarT assay in
terms of a proteome Danio rerio embryo assay (“ProDarT”)
analysing eﬀects at the proteome and thus functional level
in zebraﬁsh embryos. In environmental monitoring, pro-
teomics has been successfully applied to show sensitive and
speciﬁc toxicity-related responses in the protein proﬁles of
mussels [17]. Until today, only few proteomics approaches
on developing zebraﬁsh with toxicological background [18–
20] have been published. One of the major drawbacks is
the high abundance of yolk proteins (Vitellogenins, Vtgs)
early in development of oviparous animals, which can mask
and reduce the sensitivity for the detection of changes in
the cellular protein pattern. Ziv et al. [21] have studied the
proteome of zebraﬁsh oocytes, at a time point at which
few yolk proteins have been inoculated in the eggs. Other
researchers have applied techniques to manually remove
the yolk sacs in early embryos [22, 23]. However, these
techniquesmayinterferewiththedetectionofstress-induced
responses by the tested compounds and Vtgs could still be
identiﬁed after manual deyolking [23]. In the present paper,
eleutheroembryos (i.e., hatched but not yet free feeding
embryos) are applied since a strong decrease in yolk and
yolk proteins has been reported [19, 23–25]. As eleuthero-
e m b r y o sh a v ea l lo r g a n sd e v e l o p e d ,a r en o ts u r r o u n d e d
by a chorion, show increased activities of detoxiﬁcation
processes [26] and are free swimming, toxicodynamic, and
kinetic, toxicity processes in eleuthero-embryos might be
more similar to adults compared to embryos. To contribute
to the further advance of using ﬁsh embryos as a method
for replacement of experiments with adult ﬁsh, a two-
dimensional-gel electrophoresis-(2-DE) based proteomics
approach with 5 days old zebraﬁsh eleuthero-embryos was
applied in the present study to (i) investigate toxicity-related
responses in the embryonic protein proﬁles, (ii) characterise
the potential for sensitive and speciﬁc eﬀect assessment, and
(iii) look for candidate protein biomarkers reﬂecting the
organism health status at the molecular level.
For this purpose, eﬀects to the eleutheroembryonal
proteome caused by low eﬀect concentrations of three model
substances, which have been detected in environment and
have diﬀerent mode of action, two pesticides Rotenone and
4,6dinitro-o-cresol (DNOC) and the drug Diclofenac, were
studied.
2.ExperimentalProcedures
2.1. Fish Culture, Embryo Collection, and Eleutheroembryo
Bioassay. WIK (Wild-type India Kalcutta) zebraﬁsh were
obtained from the T¨ ubingen Zebra Fish Stock Centre at
the Max Planck Institute for Developmental Biology and
cultivated as described in K¨ uster [27]. The eleuthero-
embryo bioassays were carried out based on the OECD
Draft Guideline for testing of chemicals (OECD 2006) with
smallmodiﬁcationsduetophysicochemicalcharacteristicsof
model substances (see below).
79hpf old eleuthero-embryos were incubated for 48h in
the exposure solutions at static conditions (temperature 27±
1◦C, 12h light/dark with 30mmol photons m2s1).
The model substances were Rotenone (CAS RN 83-
79-4), 4,6-dinitro-o-cresol (DNOC, CAS RN 534-52-1),
and Diclofenac-sodium salt (CAS RN 15307-79-6). All
substances were of analytical grade and purchased from
Riedel de Haen (Rotenone and DNOC) and MP Biomedicals
(Diclofenac), respectively.
To estimate concentration-response relationships, the
model substance Rotenone was tested in the concentration
r a n g eo f0 . 2 5 n Mt o2 . 5 μM, DNOC from 0.05 to 50μM,
and Diclofenac between 1.4 and 200μM (nominal concen-
trations). Constant concentrations are assumed during the
48h exposure time with applied conditions for Diclofenac as
exposure concentrations weredemonstrated to be very stable
at the above test conditions (U. Krug, pers. communication).
Tests with DNOC were done according to OECD guideline,
that is, by using adhesive foils and an additional lid to
cover the multiwell plates to decrease possible evaporation.
The assay for Rotenone was carried out in glass vials
(instead of multiwell plates made from polystyrene) to avoid
concentration decrease during exposure due to expected
sorption because of the log KOW of 4.1 of Rotenone (EpiSuite
Vers. 4.0) as recommended by Riedl et al. [28] and Schreiber
et al. [29].
Due to the eﬀect concentrations used, it was not possible
to check for the stability of the low exposure concentrations
with the currently available analytical methods. Because of
that, no statements can be made about the real concen-
trations. As stated by [28] Riedl and Altenburger (2007)
“In ISO 14442 (2004), volatile substances are characterized
by a Henry’s constant of H ≥ 1P am 3 mol−1 (log KAW =
−3.4), highly volatile substances by H ≥ 100Pam3 mol−1
(log KAW =− 1.4). Loss of exposure concentration due to
lipophilicityisexpectedforhydrophobiccompoundswithan
octanol/water partition coeﬃcient of log KOW > 4( O E C D
SERIES ON TESTING AND ASSESSMENT Number 23,
2000).” Only Rotenone and DNOC were seen as critical in
terms of their physicochemical characteristics. So, possible
losses in the test system were tried to counteract by
the use of glass (lipophilic Rotenone, log KOW 4.1) and
covering (low volatility of DNOC, Henry constant of 1.4 ×
10
−6 atmm3/mol) to decrease the loss of substances to the
maximum.
The stock solutions for the proteomic experiment were
the same as the ones used for the concentration-response
relationships. So, although the real concentrations are not
known, the concentrations related to the eﬀect level are
similar. After exposure, all eleuthero-embryos were analysed
for lethal and sublethal eﬀects by inverse microscopy (50x
magniﬁcation, Olympus IX70-S8F, Hamburg, Germany).
Coagulation, absent blood circulation and absent heartbeat
are considered as lethal toxicological endpoints and were
used to estimate concentration-response relationships using
al o g i s t i cm o d e l( y = 100 + (−100)/(1 + (x/x0) p), with
x being the concentration in % (v/v), x0 the median eﬀect
(EC50)a n dp as the slope) (ORIGIN software, version 6.0,
Friedrichsdorf, Germany).International Journal of Proteomics 3
The estimated EC10 concentrations of these concentra-
tion-response relationships were used as the exposure con-
centration in the following proteome analysis (EC10, Rotenone
= 0.05μM; EC10, DNOC = 2.80μM; EC10, Diclofenac = 12.60μM).
For the proteomics experiments, 79hpf old eleuthero-
embryos were collectively exposed for 48h in 200mL glass
beakers with a density of one organism per 2mL exposure
solution. In the control experiments, 45 individuals were
incubated in 90mL of ISOwater (ISO 7346-3). The exposure
to the model substances was done with 50 individuals in
100mL each. After exposure, the eleuthero-embryos, which
didshowvisibleeﬀectswerediscardedandtheleftoverintact
organisms (at least 40 per replicate) were pooled in 2mL
reaction tubes and the samples were washed four times with
1mLofaqua dest. Finally, the embryos were shock frozen in
liquid nitrogen and stored at −80
◦C until analysis.
2.2. Two-Dimensional Gel Electrophoresis. The 2-DE sample
preparation was done according to G¨ undel et al. [19],
where proteins were extracted using 0.25mL lysis buﬀer
(8M Urea, 2% CHAPS, 0.5 % v/v IPGBuﬀer 47 linear (GE
Healthcare, Uppsala, Sweden) and 1% protease inhibitor
cocktail (SIGMA, Taufkirchen, Germany) for each sample
(40 pooled embryos). The subsequent 2DE was carried out
according to G¨ org et al. [30]. The isoelectric focusing (IEF)
wasperformedusingtheEttanIPGphor(GEHealthcare)and
18cm linear, pH 47 immobiline dry strips (GE Healthcare).
Rehydration was carried out at room temperature overnight
with 400μL rehydration solution per dry strip (DeStreak
solution(GEHealthcare),0.5%v/vIPGBuﬀer4–7linear(GE
Healthcare)). Fifty micrograms of protein were subjected to
IEF via cup loading on the cathode and the focussing was
performed under following conditions: 150V, 2h; 300V, 2h;
600V, 2h; 8000V gradient, 0.5h; 8000V, 11h; all steps at
20
◦C. After IEF, the immobiline dry strips were equilibrated
at room temperature according to G¨ undel et al. [19]. For
the polyacrylamide gel electrophoresis (SDS-Page), as the
second dimension, the IPG strips were sealed on the top
of 1 mm thick 14% polyacrylamide gels (Ettan DALT 12,
GE Healthcare). Vertical electrophoresis was carried out
overnight (18h) at 12
◦C and about 1W/gel. The gels were
silver stained according to Heukeshoven and Dernick [31]
and Yan et al. [32] and digitalized at a resolution of 200 dpi
using the image scanner (GE Healthcare, Uppsala, Sweden).
Subsequently, they were air dried at room temperature
between two cellophane sheets (BioRad, Munich, Germany).
2.3. Image Analysis and Statistics. Densitometric image anal-
ysis for the 2DE gels was performed with the software pack-
age Delta 2D (Version 3.4, DECODON GmbH, Germany).
The100%matchingstrategywaschosenforspotdetection.A
“fusion” gel of the experiment was created after gel matching
of all replicate 2D-gels and all proteins were detected and
edited on this virtual “fusion” gel. Subsequently, the detected
spot pattern of this fusion gel was transferred to all other
gels in the experiment. This method ensures the same spot
detectionpatternoneachgelinoneexperiment.Theamount
of protein present in a single spot was described as the
spot volume, that is, the area of the spot multiplied by
the pixel density. Individual spot volumes were normalised
to the total protein amount (e.g., all protein spots added
up together) detected within each gel and the amount of
each spot was therefore expressed as a relative volume.
All proteome analyses were run in triplicates. Due to the
inherent semiquantitative silver staining method, the 10%
largest protein spots were excluded from the normalisation
set.
Multivariate pattern and univariate spot-to-spot-
methods were applied for statistical analysis. Principal
component analysis (PCA), including all detected proteins
in one experiment, was performed with the software package
Jmp (Version 7.0, Cary, USA) to compare protein patterns
on the gels. Univariate spot-to-spot analysis was performed
using a Student’s t-test. Hereby, only spots were considered
as up- or downregulated proteins, which showed an at
least twofold diﬀerence in abundance compared to controls
and which were signiﬁcantly diﬀe r e n tf r o mc o n t r o l sw i t ha
P<. 05 or <.01 (highly signiﬁcant).
2.4. Trypsin Digestion and Identiﬁcation of Proteins. Proteins
of interest were excised from the stained gels. Following
silver removal, the spots were subjected to in-gel trypsin
digestion as previously described in Benndorf et al. [33]
Peptides were reconstituted in 0.1% formic acid, injected
by an autosampler and were concentrated on a trapping
column (nanoAcquity UPLC column, C18, 180μm × 2cm,
5μm, Waters, Eschborn, Germany) with water containing
0.1% formic acid at ﬂow rates of 15μL/min. After 4min,
the peptides were eluted onto the separation column
(nanoAcquity UPLC column, C18, 75μm × 250mm,
1.7μm, Waters, Eschborn, Germany). Chromatography
was performed by using 0.1% formic acid in solvents A
(100% water) and B (100% acetonitrile), with peptides
eluted over 30min with a 8%–40% solvent B gradient
using a nano-HPLC system (nanoAcquity, Waters) coupled
to an LTQ-Orbitrap mass spectrometer (Thermo Fisher
Scientiﬁc). Continuous scanning of eluted peptide ions
was carried out between 150–2000m/z, automatically
switching to MS/MS CID mode on ions exceeding an
intensity of 2000. Raw MS/MS spectra were converted to
mgf-ﬁles using the ProteomDiscoverer 1.0 (Thermo Fisher
Scientiﬁc). MS data were submitted to the online Mascot
(http://www.matrixscience.com, may 2009) and searched
against Danio rerio (Taxonomy ID: 7955) in the National
Centre for Biotechnology Information nucleotide database
(NCBInr, may 2009; 70,034 protein entries) tolerating
up to two tryptic missed cleavages, a mass tolerance of
10ppm for precursor ions, 0.5Da for MS/MS product ions
allowing for methionine oxidation (dynamic modiﬁcation)
and cysteine carbamido methylation (static modiﬁcation).
For the Mascot threshold, a probability score of 5% was
applied (signiﬁcance threshold: P ≤ .05). Hereby, the cutoﬀ
score value for accepting individual MS/MS spectra was
set to 0 to ensure high-sequence coverage. The identiﬁed
proteins were characterised via the Swiss-Prot and TrEMBL
(http://www.expasy.org/sprot) databases. All molecular
weights (MWs) were calculated by the online PROTPARAM
tool (http://www.expasy.org/tools/protparam.html).4 International Journal of Proteomics
3. Results
3.1. Optimisation of 2-DE Method Concerning Eleutheroem-
bryo Age. The high abundance and high number of yolk
vitellogenin (Vtgs) derivatives in protein samples of devel-
oping oviparous organisms, like the zebraﬁsh, is a major
drawback when lower abundant proteins are to be studied.
The known reduction of yolk-to-cell mass during devel-
opment [19, 23] was the basis to address this drawback
in the present study. Five days postfertilisation (120hpf),
zebraﬁsh have developed to eleuthero-embryo stages with a
strongly reduced yolk, developed mouth and are able to start
externalfeeding.Severalauthorshaveshownthatatthattime
of development the zebraﬁsh proteome is not dominated
by Vtgs anymore [19, 23, 25]. However, at 120hpf, still
some Vtg fragments could be identiﬁed in the protein
samples as is shown in Supplementary Material available
at doi:10.1155/2010/630134 (SM, Table 1) and it can be
concluded that yolk utilisation is still not at an end at the
ﬁfth day of development. But seven days after fertilisation
eleuthero-embryos starve when not fed.
Preceding the toxicoproteomics studies, the optimal
sampling time point of eleuthero-embryos combining both,
a low number of yolk proteins in the protein samples and
the avoidance of starvation stress, had to be found. To
characterise the abundance of yolk proteins in the larval
proteome,samplesderivingfromeleuthero-embryosatthree
diﬀerent time points (120hpf, 122.5hpf and 127hpf) were
studied (Figure 1). To avoid starvation, no samples from
eleuthero-embryos older than 127hpf were characterised.
Although most proteins in the three protein samples show
constant abundance at the diﬀerent measured time points,
at least two areas on the gels presented in Figures 1(a)–
1(c) were quite variable. A strong decrease of the number
and amount of the detected proteins in these areas was
observed. In previous studies, a couple of proteins of these
areas were identiﬁed as Vtg derivatives [19]. As the number
andabundanceoftheseVtgproteinshavestronglyreducedin
samples from 127hpf old eleuthero-embryos (Figure 1(c)),
eleuthero-embryos were sampled at this age/time point for
all the following proteomic analyses.
3.2. Eﬀects of DNOC, Rotenone and Diclofenac on Treated
Eleutheroembryos at Phenotypic Level. The choice of relevant
concentrations for the toxicoproteomics experiments with
the three tested chemicals was based on the previous char-
acterisation of eﬀects at higher levels of biological organisa-
tion (morphological, physiological eﬀects) in the eleuthero-
embryos. Eﬀect detection in eleuthero-embryos was done
similar to the DarT[ 5] in terms of test regime, exposure
time and toxic endpoints. The 48-hour-long exposure in the
toxicant solutions started at around 79hpf when most of the
eleuthero-embryos did hatch.
All three substances caused concentration-dependent
lethaleﬀectsintheorganisms.Concentration-eﬀectrelation-
ships based on lethal endpoints are shown in Figure 2.T h e
potency of Rotenone (EC50= 0.068 ± 0.00μM) was strongest
compared to DNOC (EC50= 3.0 ± 0.05μM) and Diclofenac
(EC50= 23 ± 1.08μM). The slopes obtained for the modelled
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Figure 1: Changes in proteome patterns of eleuthero-embryos at
three diﬀerent time points (a) at 120hpf, (b) at 122.5hpf and (c) at
127hpf. Areas with most obvious changes are encircled. Number
and abundance of proteins in these areas clearly decrease over
time. Proteins identiﬁed as vitellogenin derivatives are labelled by
asterisks (∗).
concentration-eﬀect relationships for Rotenone (8.75±2.25)
andDNOC(12±1.80)werequitesteepandexceededtheone
estimated for Diclofenac (4.75±1.65) exposure in eleuthero-
embryos. Rotenone and DNOC solely caused coagulation
of the organisms, whereas diverse eﬀects in the eleuthero-
embryos were detected after exposure to Diclofenac. TheseInternational Journal of Proteomics 5
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Figure 2: Microscopically visible lethal eﬀects of Rotenone,
DNOC and Diclofenac to eleuthero-embryos studied after 48h
exposure. Concentration-eﬀect relationships based on a logistic
model are shown. Parameter estimates were as follows: Rotenone:
EC50 [μM] = 0.068±0.00, p = 8.750±2.25, DNOC: EC50 [μM] =
3.007 ± 0.05, p = 12.311 ± 1.80, Diclofenac: EC50 [μM] = 23.076 ±
1.08, p = 4.746 ±1.65.
eﬀects included coagulation and lethal impairments in the
cardiovascular system but also, to a minor extent, oedema in
heart and yolk region or malformations of the backbone.
3.3. Toxicoproteomics with Zebraﬁsh Eleutheroembryos Using
t h eT h r e eT o x i c a n t sR o t e n o n e ,D N O C ,a n dD i c l o f e n a c .
Rotenone, DNOC and Diclofenac were selected as model
substanceswithdiﬀerentmodesofactiontostudythepoten-
tial of proteomics for sensitive and speciﬁc eﬀect detection.
Althoughtheyhavediﬀerentmoleculartoxicitytargets,both,
Rotenone and DNOC, aﬀect the respiratory chain and were
chosen because of their action in an important primary
metabolic pathway. The insecticide Rotenone binds, as a
primary toxicity target, to the PSST-subunit of complex 1
of the electron chain and inhibits the oxidative phosphory-
lation [34]. The insecticide and herbicide DNOC acts as a
decoupler of the mitochondrial oxidative phosphorylation
by decoupling of the electron transport process from ATP
synthesis [35]. The pharmaceutical Diclofenac, as an anti-
inﬂammatory drug, inhibits the cyclooxygenases COX1 and
COX2[36]andwaschosenasatoxicantaﬀectingasecondary
biochemical pathway by inhibiting the prostaglandin synthe-
sis.
For all three substances, the modelled low-dose EC10
concentrations were selected for the proteome stud-
ies (EC10 Rotenone = 0.05μM, EC10 DNOC = 2.80μM,
EC10 Diclofenac = 12.60μM). To avoid interpretation problems
due to aggregating eﬀects at the protein level for aﬀected
and nonaﬀected embryos, only those exposed eleuthero-
embryos were included in the 2DE experiments that did not
show physiological or morphological eﬀects. This procedure
should allow the detection of stress induced changes at
the molecular level prior the occurrence of microscopically
visible eﬀects.
In Figure 3, the typical proteome pattern from control
eleuthero-embryos (a) and eleuthero-embryos treated with
the EC10 concentrations of Rotenone (b), DNOC (c) and
Diclofenac (d) are depicted. Clear diﬀerences between the
samples and controls are indicated by encircled areas. Two
statistical approaches, based on univariate and multivariate
analyses tools were applied for the detection of toxicity
related changes in the eleuthero-embryo proteome [37].
3.3.1. Principal Component Analysis (PCA). It was per-
formed to analyse the whole proteome pattern of exposed
and nonexposed organisms. The received PCA scores for
the tested toxicants are shown in Figure 4. The PCA
distinguished between control and treatment groups for all
three substances.
For all chemicals, the ﬁrst component (PC1) provided
separation between the control and treatment groups (Fig-
ures4(a)–4(c)).PC2andPC3,incontrast,didnotcontribute
information to distinguish between control- and exposure-
protein patterns but accounted for variances within the
replicates. The percentage contributions for PC1, PC2, and
PC3 for each toxicant are shown in Figure 4.
3.3.2. Univariate Spot-to-Spot Analysis. It was performed as
a way of analysing the 2-DE experiments to obtain detailed
information about single proteins changed in expression or
abundance after treatment. Results from univariate analysis
are shown in Figure 5 and Table 1.
Overall, Rotenone (EC10) caused the highest percentage
of signiﬁcantly changed proteins (24.1%), followed by
DNOC (EC10) with 10.8% and by Diclofenac (EC10)w i t h
6.8%. This order is not changed if only the high-signiﬁcant
changed proteins (P<. 01) are considered (indicated in
Figure 5 and Table 1). The results from univariate spot-to-
spotanalysismirrortheresultsfromthemultivariateanalysis
showing a sharp separation between control and treatment
protein pattern for Rotenone, less clear separation of the
treatment conditions for DNOC and low diﬀerence between
control and treatment groups for Diclofenac (Figure 4).
The spot IDs, relative volumes, standard distributions and
Student’s t-test results for all diﬀerentially expressed proteins
obtained from treatment with the single substances are
shown on 2-DE gels and tables in the Supplemental Material
(Figures SM1 and SM2, Tables 3–5).
3.4. Comparison of Results from Toxicoproteomics Experiments
with Rotenone, DNOC, and Diclofenac. Changes in the
eleuthero-embryo proteome pattern from all treatment con-
ditions (Rotenone, DNOC and Diclofenac) were compared
to enable the diﬀerentiation between unspeciﬁc from model
substance speciﬁc reactions. Comparison was realised on
pattern-(Figure 6(a)) and individual-protein level (Figures
6(b) and 6(c)).6 International Journal of Proteomics
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Figure 3: 2-DE gels from proteomics experiments: (a) control conditions, (b) EC10 treatment with Rotenone, (c), EC10 treatment with
DNOC and (d) EC10 treatment with Diclofenac. All protein samples were separated under the same 2-DE conditions: Immobiline strips pH
4–7 in the ﬁrst and 14% PAA gels in the second dimension.
All obtained control protein patterns could be clearly
distinguished from treatment situations by principal com-
ponent 1 (Figure 6(a)) whereas PC2 separated controls
belonging to diﬀerent experiments. PC1 also provided a
separation between proteome patterns of Rotenone treated
eleuthero-embryos and the other treatments. PC3 sorted the
protein patterns according to all three diﬀerent treatment
groups (Figure 6(a)). These results were conﬁrmed consid-
ering the comparison at the individual protein level, which
is demonstrated in the Venn diagram in Figure 6(b).S o ,e a c h
modelsubstancecauseditsownsetofdiﬀerentiallyexpressed
proteins.
However,nexttosubstancespeciﬁcchangedproteinsalso
proteins were detected, which showed changed expression
levels independent of substance identity. These are indicated
on the 2DE gel in Figure 6(c) and in the Supplemental Mate-
rial (SM, Table 2) . Nine proteins could be detected, which
simultaneously changed expression levels after Rotenone,
DNOC, and Diclofenac treatment. These might be a base set
forthedevelopmentofgeneralstressbiomarkersfortheindi-
cation of exposure. This was conﬁrmed by ﬁrst identiﬁcation
results of those proteins that had been associated with stress
by Monsinjon and Knigge [37]( T a b l e2).
4. Discussion
Improvement of knowledge about toxic responses and
regarding information on sensitivity and speciﬁcity of eﬀect
assessment might contribute to the advance of the zebraﬁsh
embryo test for testing of chemicals as animal replacementInternational Journal of Proteomics 7
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Figure 4: Principal component analysis scores (PC1, PC2, and PC3) for protein pattern assessment of control and treated eleutheroembryos
with (a) Rotenone, (b) DNOC, and (c) Diclofenac. Control groups are indicated with c. Three independent replicates were performed for
all treatment groups (EC10 treatment with either Rotenone, DNOC, or Diclofenac).
Table 1: Summary of results from spot-to-spot analysis for all performed toxicoproteomics experiments: Diclofenac (EC10), Rotenone
(EC10) and DNOC (EC10). Numbers and percentage (in relation to total protein number on the gel) of signiﬁcantly (P<. 05) and highly-
signiﬁcantly (P<. 01) at least twofold changed proteins are indicated in the table. Data are sorted for up-regulated (oe, ratio sample/control
>2)anddown-regulated(rp,ratiosample/control<2)proteins.Inaddition,thesumorpercentageofallchangedproteinsforeachcondition
is shown (rp and oe).
Toxi Compound
Total number of
Proteins
detected on the
gels
P value rp [number
of proteins]
rp
[%]
oe [number
of proteins]
oe
[%]
rp and oe [number
of proteins]
rp and oe
[%]
Diclofenac 814 0.05 14 1.7 41 5.0 55 6.8
814 0.01 4 0.5 15 1.8 19 2.3
Rotenone 860 0.05 91 10.6 116 13.5 207 24.1
860 0.01 39 4.5 68 8.4 107 12.9
DNOC 703 0.05 20 2.8 56 8.0 76 10.8
703 0.01 5 0.7 17 2.4 22 3.1
method for regulatory purposes. The aim of the present
paper was to characterise the potential of proteomics with
zebraﬁsh eleuthero-embryos for sensitive and speciﬁc eﬀect
assessment of chemical exposure, which, to our knowledge,
has not been studied so far. Hereby, the main questions
to be answered were whether toxicity related responses can
be detected at low-dose ranges in the proteome proﬁles of
treated eleuthero-embryos, whether exposure with diﬀerent
model substances can be discriminated at the proteome
level and whether possible candidate protein biomarkers for
predictive eﬀect diagnosis might be proposed. Therefore,
proteomics was established for zebraﬁsh eleuthero-embryos
and proteomic analyses were performed with three diﬀerent
compounds, including two insecticides, aﬀecting primary
metabolic pathways (oxidative phosphorylation), Rotenone
and DNOC [38, 39], and the pharmaceutical Diclofenac,
with an anti-inﬂammatory mode of action [36].
The results will be discussed in two parts. Firstly,
methodological aspects including eleuthero-embryo age and
the applied model substances are discussed. In the second
part, the discussion is related to the results of the proteomic
experiments.8 International Journal of Proteomics
Table 2: Summary of positive identiﬁcation of protein spots changed in expression after exposure to EC10 concentrations of Rotenone (R),
DNOC (D) and Diclofenac (Dic) to zebraﬁsh eleuthero-embryos.
Spot Mascot
Score Protein Name UniProtKB
Accession
Peptides
assigned
Sequence
coverage
[%]
MWobs/cal
[kDa] pIobs/cal
Ratio
Rotenone
Ratio
DNOC
Ratio
Diclofenac
Dic11o, D, R 430.29 vitellogenin 1 Q1LWN2 12 8.7 30.0/128.0 5.6/8.68 13.6 4.1 2.4
Dic14o, D, R 94.0 LOC553473
(β-crystallin) Q502C7 5 10.8 24.5/27.6 5.9/7.67 47.3 3.1 3.0
Dic27o, D, R 197.79 actin, alpha,
cardiac muscle 1a Q6IQR3 10 23.1 45.0/42.0 5.6/5.22 3.3 3.6 2.3
Dic47o, D, R 644.34 tubulin, beta 2c Q6P5M9 25 25.8 44.0/49.8 5.5/4.79 40.6 12 26.5
Dic64r, D, R 321.38 myosin, light
polypeptide 2 O93409 14 50.3 17.0/18.9 4.7/4.39 0.4 0.5 0.5
EC10
DNOC
EC10
Rotenone
EC10
Diclofenac
rp α<0.05 r<2
rp α<0.01 r<2
oe α<0.05 r>2
oe α<0.01 r>2
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Figure 5: Summary of results from spot-to-spot analysis of
proteomics experiments with Diclofenac (Dic), Rotenone(R), and
DNOC (D). For all tested concentrations the percentages of protein
spots, related to all detected protein spots in the 2-DE experiment,
are depicted that show signiﬁcant (P<. 05) or highly signiﬁcant
changes (P<. 01) and a minimum of twofold changed expression
levels compared to controls. Proteins showing an at least twofold
increaseinabundancecomparedtocontrol(r<2)areconsideredas
upregulated(oe),allproteinsshowinganatleasttwofolddecreasein
abundance compared to controls are considered as downregulated
(rp).
4.1. Methodological Aspects
4.1.1. Eleutheroembryo Age. In contrast to adult animals,
proteome analysis of developing organisms addresses a
biological system that is highly variable in terms of phys-
iological, morphological, and other parameters over time,
which is very likely to be mirrored at the molecular level.
Hence, the exact sampling point of eleuthero-embryos for
the proteomics studies is of concern. Eleuthero-embryos
were sampled at 127hpf for the proteome analyses for two
reasons. On the one hand, the observed shift of the 2DE
protein patterns from yolk proteins towards cellular proteins
during embryonal development [19, 23]i sn e a r l yc o m p l e t e d
at this developmental stage and Vtg rich areas on the gels
are not predominant anymore. On the other hand, 127hpf
old eleuthero-embryos are vital and do not show signs
of starvation, which could be assumed if yolk is nearly
utilised and no external feeding of the organisms would
take place. To our knowledge, the point of time of complete
yolk consumption in Danio rerio has not been investigated
so far. However, yolk utilisation may strongly depend on
many parameters including movements of the eleuthero-
embryos, temperature or light conditions. These parameters
might vary slightly for each biological sample deriving
from eleuthero-embryos and could lead to diﬀerences in
the proteome pattern. Hence, for all performed proteomic
experiments controls from the same spawning event as the
treated samples were included. This is also proposed for any
future applications of proteomics with zebraﬁsh eleuthero-
embryos.
4.1.2. Concentrations Tested. The output of a proteomics
experimentstronglydependsontheappliedmodelsubstance
concentrationsandexposuretimesandshouldbeinterpreted
in relation to observed eﬀects at higher biological organi-
sation levels in the analysed organisms. As a shortcoming
we have to state that it was not possible to quantify the
exact concentrations mainly due to the low concentrations
of two of the substances (EC10), the volumes used and the
respective limits of quantiﬁcation. In spite of the above,
all eﬀects on higher organisation levels like morphological,
physiological or behavioural eﬀects are preceded by eﬀects
at the molecular level [11]. Proteomics investigations at
substance concentrations or exposure times that do not
cause any microscopically visible eﬀects in the organisms
may lead to the identiﬁcation of proteins involved in the
primary response or adaptation processes after exposure
[17, 18, 40]. This could be used for prediction of eﬀects at
higher organisation levels [37]. However, without relation to
eﬀectsatthephenotypiclevel,theselectionofconcentrations
or exposure times causing detectable relevant eﬀects at the
proteome levelmightbe diﬃcult. Butthe discussionofexpo-
sure concentrations in relation to concentration dependent
phenotypic eﬀects for the proteomics experimental setup
has not been focus of many ecotoxicoproteomics studies so
far [17]. The investigation of low-eﬀect concentrations likeInternational Journal of Proteomics 9
EC10
Control
Control
Diclofenac EC10
DNOC EC10
Rotenone EC10
20 10 0 −10 −20
PC1 (20.3%)
−20
−10
0
10
P
C
3
(
1
0
.
6
%
)
−20
−10
0
10
P
C
2
(
1
0
.
9
%
)
(a)
Rotenone
171
DNOC
52
Diclofenac
31
13
9
14
1
(b)
D071o,R Dic59r,R
Dic27o,D,R
Dic66r, R Dic23o,R
Dic47o,D,R
Dic17o,R
Dic35o,R
Dic57r,R
Dic62r,R
Dic12o,D,R
Dic14o,D,R
Dic13o,R
Dic48o,R
Dic19o, D,R
Dic15o, D,R
Dic41o, D,R
Dic51o,D
Dic64r, D,R
Dic61r,R
D099r,R
D041o,R
D078o,R
D106r,R
D069o,R
Dic22o,R
D112r, R
D108r,R
Dic29o,R
Dic60r,R
Dic31o,R
D050o,R Dic11o,D,R D034o,R
D048o,R
D049o,R
D083o,R
7 6 5 4
14.4
18.4
25
35
45
66.2
116
(
k
D
a
/
p
H
)
Diclofenac and DNOC and Rotenone
DNOC and Rotenone
Diclofenac and Rotenone
Diclofenac and DNOC
(c)
Figure 6:Comparisonofresultsfromtoxicoproteomics experiments withRotenone, DNOC,andDiclofenac exposure. (a)PCAscoreswhen
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EC10 as done here with a proteomics approach in intact
organisms enables both, the testing of a toxicity relevant
concentration and the analyses of molecular eﬀects, which
precede phenotypic physiological or morphological eﬀects.
4.2. Proteomics Experiments: Sensitivity and
Speciﬁcity of Responses
4.2.1. Sensitivity. One question of the present study was
whether toxic stress can be detected in the proteome of
treated zebraﬁsh eleuthero-embryos that do not show a
microscopically visible damage. By application of multivari-
ate and univariate methods for the analysis of the proteomics
data, proteome pattern of control and treated but intact
eleuthero-embryos could clearly be distinguished at low sub-
lethal concentrations of Rotenone, DNOC and Diclofenac. It
can be concluded that the proteomics approach for all anal-
ysed substances lead to detection of a response at the molec-
ular level in eleuthero-embryos not showing microscopically
visible lesions. This would conﬁrm the suggested scope of
toxicogenomics approaches [11, 37, 40]t os e n s i t i v e l yd e t e c t
eﬀectsatthemolecularlevelpriortotheoccurrenceofeﬀects
at the phenotypic level and the deﬁnition of marker proteins,
which might be used for predictive eﬀect diagnosis [41].
4.2.2. Speciﬁcity. The characterisation of the speciﬁcity of
the detected response to treatments with diﬀerent substances
with the applied proteomics approach was a further major
concern in the present study. In terms of speciﬁcity, the
established DarT assay sometimes has limitations [6, 10].
The results of the DarT as performed in this study conﬁrm
such concerns as less speciﬁc reactions were detectable at
the phenotypic level after Rotenone, DNOC and Diclofenac
treatment. Observed eﬀects caused by the three diﬀerent
substances were quite similar and coagulation was predom-
inant. Early responses at the molecular level are supposed
to be more related to substance speciﬁc eﬀects [11] that
could also give hints to mode of action and mechanisms of
toxicity of the tested substances [41]. This is supported by
PCA based pattern analyses clearly distinguishing between
proteomes of eleuthero-embryos treated with the diﬀerent
model substances. Moreover, each tested substance caused
its own speciﬁc pattern of changed proteins and hence, its
own protein expression signature (PES). The term PES was
i n t r o d u c e db yB r a d l e ya n dc o w o r k e r s[ 42, 43]t od e ﬁ n ea
set of proteins diﬀering between contaminant exposure and
control. Shrader et al. [20] demonstrated the applicability
for PES to distinguish between diﬀerent exposure scenarios
withendocrine-disruptioninzebraﬁshembryos.Bystudying
mussels from diﬀerent polluted ﬁeld sites, Knigge et al. [44]
also described a subset of proteins forming a classiﬁer to
distinguish between polluted and unpolluted situations. PES
can enable the identiﬁcation of substance speciﬁc biomarker
patterns, which are considered to provide an overcome of the
uncertainties associated with the extraction of single protein
markers as described by Knigge et al. [44] and Monsinjon
and Knigge [37]. This was also shown in a toxicogenomic
study that described speciﬁc gene expression proﬁle pattern
inzebraﬁshembryosenablingthediscriminationofexposure
against 11 model compounds [16] or by a toxicoproteomics
study of marine pollutants on mussels [17]. Hence, with our
results having identiﬁed speciﬁc protein patterns for each
exposure scenario would support the concept of PES and the
idea of extracting information for certain exposure scenarios
solely from changed protein patterns without the need to
identify single proteins.
The PES of each substance was mainly determined by
the number of changed proteins. For all three substances
the same eﬀect concentration, which lead to microscopically
visible eﬀects in 10% of the treated organisms (EC10), was
tested with the toxicoproteomic approach. At the molecular
level, however, in terms of the number of diﬀerentially
expressed proteins, diﬀerences in the eﬀect levels could be
detected for all three substances. At EC10 concentration,
Rotenone caused the change of about 24% of all detected
proteins, DNOC of about 11% and Diclofenac of about 7%
of all proteins. So, the observed eﬀect level at the molecular
level diﬀers from the eﬀect level derived from analysis of
visible toxic endpoints at the phenotypic level but, interest-
ingly, correlated well with the determined potencies of the
substances. Most detected proteins from whole embryonic
ﬁsh proteomic studies are likely to belong to high-abundant
protein classes such as cellular organisation or metabolic
pathways. These have been previously associated with toxic
stress [37]. Thus, it might be stated that the number of
changed proteins in ecotoxicoproteomics studies of whole
organismsmight correlatewiththestressordecompensation
status of the organism.
Analysing the number of changed proteins the eﬀect
analysis at the proteome level could give information on
how basal the aﬀected metabolic pathways are in contrast
to classical toxic endpoints. Rotenone and DNOC have
a mode of action in a primary metabolic pathway, the
oxidative phosphorylation [38, 39]. Both substances caused
an eﬀect on a higher number of proteins in the proteome
compared to Diclofenac with the primary mode of action
in a secondary biochemical pathway (inhibition of cyclooxy-
genases) [36]. Direct impairments in energy metabolism
aﬀect many cellular processes and enzymes and are in direct
relation to changed rates of biosyntheses, as general protein
biosynthesis, all of which uses up ATP. Hence, changes of
many proteins in the larval proteome after Rotenone or
DNOC treatment may well be considered as plausible. For
Rotenone, this was also conﬁrmed by a proteomics study
from Jin et al. [45] who identiﬁed 110 signiﬁcantly changed
mitochondrial proteins in Rotenone exposed dopameric cell
lines. The reversibility of mode of action from Rotenone
and DNOC and the multiple other actions described for
Rotenone [46–48] might be consulted for explaining the
highernumberofchangedproteinsafterRotenonetreatment
compared to DNOC. Future protein identiﬁcations would
helptoobtaincloserinsightsinmechanismsoftoxicityofthe
tested substances but were not within the scope of this study.
4.2.3. General Stress Markers. Although speciﬁc PES were
detectable for Rotenone, DNOC and Diclofenac, spot-to-
spot analyses revealed 9 proteins that showed concurrentlyInternational Journal of Proteomics 11
and signiﬁcantly changed expression levels after treatment
with all substances. Apraiz and co-workers [17] have intro-
duced the term “minimal PES” for the set of generally
responding proteins. These proteins seem to respond to a
wider variety of toxic stress and might provide an origin
for the development of unspeciﬁc biomarkers distinguishing
between control and exposure scenarios.
Identiﬁcation results have shown that one of these
proteins matched to vitellogenin sequences. Vitellogenins
are yolk proteins that serve in embryonic nutrition and
which decrease in abundance during development [19, 23].
An increased abundance of those vitellogenins (Vtg) in
exposed eleuthero-embryos might indicate retardation in
developmentoftheexposedeleuthero-embryosatthemolec-
ular level, which can hardly be followed with microscopy
based methods. As the detected Vtg protein is a Vtg
fragment, endocrine disrupting processes, which have been
also associated with (full-length) Vtg expression [15]a r en o t
assumed here.
In addition, three cytoskeleton proteins (myosin, actin,
and tubulin) were identiﬁed. This is in accordance to other
toxicoproteomics studies, which have found cytoskeleton
proteins associated with toxic responses [17, 37]. The
cytoskeleton has been proposed to be one of the ﬁrst targets
of oxidative stress [49] and Apraiz et al. [17]h a v ee x t e n s i v e l y
discussedtheexpressionchangeoftubulin,whichtheyfound
to be part of the minimal PES after exposure of mussels
to three diﬀerent chemicals. Shi et al. [18] also described
that cytoskeleton maintenance was predominantly aﬀected
in zebraﬁsh larvae after PFOS exposure and Manduzio et
al. [50] found altered expression of actins and myosins in
mussels as indication for water pollution. Although, there
is also criticism about housekeeping proteins to be good
marker proteins [37], our results support studies, which
have shown that toxic exposure might lead to signiﬁcant
changes in abundance of cytoskeleton proteins. These could
serve as markers to monitor the health status of an organ-
ism.
β-crystallin also responded to exposure with all three
substances. Crystallins are the dominant structural com-
ponents of the vertebrate eye lens and alteration in its
expression might be connected to disturbed embryonal
eye development. A connection of toxic exposure and
lens degeneration in ﬁsh has been recently published [51]
Moreover, Shi et al. [18] have detected a correlation of γ-
crystalline expression and toxic stress in protein proﬁles of
PFOS treated zebraﬁsh larvae.
Itcanbeconcludedthattheestablishedtoxicoproteomics
approach with zebraﬁsh eleuthero-embryos enabled the
detection of candidate protein markers indicating devel-
opmental impairments and toxic stress at the molecular
level prior the manifestation of visible lesions. Perceivable
next steps will concentrate on assay development such as
enzyme assays or Western blots for some of the found
protein markers. This enables the analysis of robustness and
exposure-time and exposure-concentration dependence of
the found protein signals after exposure to chemical stress
and to characterise their potential to be stress biomarkers in
Danio rerio embryos.
5. Conclusions
Proteomics was established for eleuthero-embryos of the
zebraﬁsh (Danio rerio). With univariate and multivariate
statistical analysis tools, the potential of this approach was
conﬁrmed to sensitively detect eﬀects in organisms treated
with low toxicant concentrations of the model substances
Rotenone, DNOC, and Diclofenac. The diﬀerent exposure
scenarios could be distinguished at the molecular level as
each substance caused its own protein expression signature.
Moreover, it was shown that proteomic investigations hold
thepossibilitytodetectcandidateproteinmarkersthatmight
serve as general stress markers indicating the health status
of an organism and be usable for early diagnosis of toxic
stress. Thus, an extension of DarT to the study of eﬀects
at the proteome level (ProDarT) promises to allow a more
sensitive, speciﬁc and reﬁned toxicity assessment.
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